BONUS ZERTIFIKAT - SIEMENS HEALTHINEERS Share Price

Certificat

DE000VD15G49

Market Closed - Boerse Frankfurt Warrants 18:54:57 13/05/2024 BST
65.65 EUR +0.63% Intraday chart for BONUS ZERTIFIKAT - SIEMENS HEALTHINEERS
Current month+4.11%
1 month+3.52%
Date Price Change Volume
13/05/24 65.65 +0.63% 0
10/05/24 65.24 +0.34% 0
09/05/24 65.02 +1.80% 0
08/05/24 63.87 +1.30% 0
07/05/24 63.05 -1.47% 0

Real-time Boerse Frankfurt Warrants

Last update May 13, 2024 at 06:54 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying SIEMENS HEALTHINEERS AG
IssuerLogo Issuer Vontobel Vontobel
WKN VD15G4
ISINDE000VD15G49
Date issued 15/03/2024
Strike 75
Maturity 20/12/2024 (221 Days)
Parity 1 : 1
Emission price 68.07
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 68.95
Lowest since issue 59.16
Spread 1.41
Spread %2.10%

Company Profile

Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows: - sale of imaging equipment and solutions (53%); - sale of diagnostic equipment (21%); - sale of solutions and services for cancer care (16.6%); - sale of advanced therapeutic solutions (9.4%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery. Net sales are distributed geographically as follows: Germany (4.9%), Europe/CIS/Africa/Middle East (27.3%), the United States (34.6%), America (6.3%), China (13%) and Asia/Pacific and Japan (13.9%).
Sector
-
More about the company

Ratings for Siemens Healthineers AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Siemens Healthineers AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
52.78 EUR
Average target price
60.47 EUR
Spread / Average Target
+14.56%
Consensus